Drug Recall: Coated APAP 500 mg Caplets for CGMP Deviations
ULTRAtab Laboratories, Inc. is recalling approximately 2 million Coated APAP 500 mg caplets due to current Good Manufacturing Practice (CGMP) deviations. The bulk product was distributed to three distributors who may have distributed finished product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II drug recall for CGMP deviations with no reported illnesses or injuries. CGMP violations are manufacturing control and process issues rather than direct safety hazards. The source text does not indicate that any illness, injury, or specific hazard has been identified in the product itself.
Plain-English summary
ULTRAtab Laboratories, Inc., located in Highland, New York, is recalling Coated APAP 500 mg caplet (Acetaminophen 500 mg) in bulk containers. The recall involves approximately 2,048,941 tablets with product code L206L and bulk lot 19B002.
The recall was initiated by the manufacturer on January 26, 2022, due to Current Good Manufacturing Practice (CGMP) deviations. CGMP deviations relate to the manufacturing processes and controls used to produce the drug.
The bulk product was distributed to 3 distributors, who may have distributed finished product containing the affected material. Consumers or healthcare providers who have this product should contact the recalling firm or their distributor for instructions on return or disposal.
The FDA classified this recall as Class II on February 9, 2022. The recall was terminated on January 7, 2025.
The recalled product
- Product
- Coated APAP 500 mg caplet (Acetaminophen 500 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-206-00
- Manufacturer
- ULTRAtab Laboratories, Inc.
- Hazard
- cgmp-deviation
- manufacturing-control
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Product Codes: L206L Bulk Lots: 19B002
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27